Stoke Therapeutics Inc (STOK) — Cash Flow Reinvestment Rate
Stoke Therapeutics Inc (STOK) has a Cash Flow Reinvestment Rate of 0.10x as of March 2025, reinvesting $13.78 Million (capex $152.00K plus investments $13.63 Million) from operating cash flow of $131.83 Million. Check STOK cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Stoke Therapeutics Inc Cash Flow Reinvestment Rate (2025–2025)
Historical reinvestment intensity for Stoke Therapeutics Inc across 1 annual periods. Explore STOK long-term asset investment ratio to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Stoke Therapeutics Inc (2025–2025)
Year-by-year capital reinvestment analysis for Stoke Therapeutics Inc. For live market cap and broader valuation context, see Stoke Therapeutics Inc market cap and net worth.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 4.10x | $186.81 Million | $45.59 Million | $670.00K | — |